160 related articles for article (PubMed ID: 19956393)
21. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma.
Lin XD; Chen SQ; Qi YL; Zhu JW; Tang Y; Lin JY
J Surg Oncol; 2012 Jul; 106(1):94-100. PubMed ID: 22231149
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of SPARC gene expression in patients with gastric cancer.
Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
[TBL] [Abstract][Full Text] [Related]
24. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
25. Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas.
Dizdar L; Tomczak M; Werner TA; Safi SA; Riemer JC; Verde PE; Stoecklein NH; Knoefel WT; Krieg A
Oncol Lett; 2017 Dec; 14(6):6847-6856. PubMed ID: 29109763
[TBL] [Abstract][Full Text] [Related]
26. Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?
Ingold B; Simon E; Ungethüm U; Kuban RJ; Müller BM; Lupp A; Neumann U; Ebert MP; Denkert C; Weichert W; Schulz S; Röcken C
PLoS One; 2010 Apr; 5(4):e10087. PubMed ID: 20386750
[TBL] [Abstract][Full Text] [Related]
27. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
29. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of "Double-hit" and "Double-protein" expression in Primary Gastric B-cell Lymphomas.
He M; Chen K; Li S; Zhang S; Zheng J; Hu X; Gao L; Chen J; Song X; Zhang W; Wang J; Yang J
J Cancer; 2016; 7(10):1215-25. PubMed ID: 27390596
[TBL] [Abstract][Full Text] [Related]
31. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
32. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.
Zheng H; Takahashi H; Nakajima T; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Dec; 132(12):817-23. PubMed ID: 16807756
[TBL] [Abstract][Full Text] [Related]
33. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
34. The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.
Murakawa M; Aoyama T; Miyagi Y; Kobayashi S; Ueno M; Morimoto M; Numata M; Yamamoto N; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
J Cancer; 2019; 10(3):627-633. PubMed ID: 30719160
[No Abstract] [Full Text] [Related]
35. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract][Full Text] [Related]
36. Expression and significance of IGF-2, PCNA, MMP-7, and α-actin in gastric carcinoma with Lauren classification.
Kuang RG; Wu HX; Hao GX; Wang JW; Zhou CJ
Turk J Gastroenterol; 2013; 24(2):99-108. PubMed ID: 23934455
[TBL] [Abstract][Full Text] [Related]
37. Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.
Guo T; Yu Y; Yip GW; Baeg GH; Thike AA; Lim TK; Tan PH; Matsumoto K; Bay BH
Histopathology; 2015 Mar; 66(4):491-9. PubMed ID: 25270600
[TBL] [Abstract][Full Text] [Related]
38. SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.
Khetan K; Baloda V; Sahoo RK; Vishnubhathla S; Yadav R; Saraya A; Sharma A; Gupta SD; Das P
Pathol Res Pract; 2019 Dec; 215(12):152685. PubMed ID: 31727501
[TBL] [Abstract][Full Text] [Related]
39. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.
Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L
Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]